Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San

Pharmaceutical Biology

Volumn 51, Issue 10, 2013, Pages 1219-1227

  Wang, Yu Qing ^a   Zhang, Jie Qiong ^a   Liu, Chun Hua ^a   Zhu, Dan Ni ^a   Yu, Bo Yang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ophiopogon japonicas; Panax ginseng; Schisandra chinensis; Traditional Chinese medicine

Indexed keywords

ANGELOYLGOMISIN H; BENZOYLGOMISIN H; BENZOYLGOMISIN Q; BUTANOL; CHINESE DRUG; CREATINE KINASE; GINSENOSIDE; GINSENOSIDE RF; GINSENOSIDE RG 2; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 4; GINSENOSIDE RK 1; GOMISIN; GOMISIN A; GOMISIN E; LACTATE DEHYDROGENASE; LIGNIN; MALONALDEHYDE; MYELOPEROXIDASE; PROPRANOLOL; PROTECTIVE AGENT; SCHISANTHERIN A; SCHIZANDRIN B; SCHIZANDROL A; SHENG MAI SAN; SUPEROXIDE DISMUTASE; TIGLOYLGOMISIN P; TRIGLOYLGOMISIN H; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SCREENING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART PROTECTION; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; T WAVE AMPLITUDE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CHROMATOGRAPHY, LIQUID; CREATINE KINASE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; MYOCARDIAL INFARCTION; MYOCARDIUM; PEROXIDASE; PHYTOTHERAPY; PLANTS, MEDICINAL; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY;

EID: 84883210026     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.784920     Document Type: Article

References (37)

1. Bhayana V, Henderson AR. (1995). Biochemical markers of myocardial damage. Clin Biochem 28: 1-29.
2. Chen X. (1996). Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 23: 728-32.
3. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. (1994). Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94: 437-44.
4. Deng J, Wang YW, Chen WM, et al. (2010). Role of nitric oxide in ginsenoside Rg1-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull 33: 631-5.
5. Esterbauer H. (1993). Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 57: 779S-85S.
6. Fan XH, Wang Y, Cheng YY. (2006). LC/MS fingerprinting of Shenmai injection: A novel approach to quality control of herbal medicines. J Pharm Biomed Anal 40: 591-7.
7. Fontes JP, Goncalves M, Ribeiro VG. (1999). Serum markers for ischemic myocardial damage. Rev Port Cardiol 18: 1129-36.
8. Galeotti L, Strauss DG, Ubachs JF, et al. (2009). Development of an automated method for display of ischemic myocardium from simulated electrocardiograms. J Electrocardiol 42: 204-12.
9. Ghisalberti EL. (1997). Cardiovascular activity of naturally occurring lignans. Phytomedicine 4: 151-66.
10. Hanninen H, Takala P, Rantonen J, et al. (2003). ST-T integral and T-wave amplitude in detection of exercise-induced myocardial ischemia evaluated with body surface potential mapping. J Electrocardiol 36: 89-98.
11. Harrison J, Schultz J. (1976). Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251: 1371-4.
12. He F, Guo R, Wu SL, et al. (2007). Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. J Cardiovasc Pharmacol 50: 314-20.
13. Jiang WL, Zhang SM, Tang XX, Liu HZ. (2011). Protective roles of cornuside in acute myocardial ischemia and reperfusion injury in rats. Phytomedicine 18: 266-71.
14. Kim H, Chen X, Gillis CN. (1992). Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochem Biophys Res Commun 189: 670-6.
15. Li G, Wei ZL, Zheng XL. (2002). Effect of ginsenoside-Rb1 on cardiomyocyte apoptosis after ischemia and reperfusion in rats. J Huazhong Univ Sci Technol (Health Sci) 22: 212-15.
16. Li L, Pan Q, Han W, et al. (2007). Schisandrin B prevents doxorubicininduced cardiotoxicity via enhancing glutathione redox cycling. Clin Cancer Res 13: 6753-60.
17. Li X, Zhao B, Liu G, Xin W. (1990). Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations. Free Radic Biol Med 9: 99-104.
18. Liu Y, Lin R, Shi XL, et al. (2011). The roles of buyang huanwu decoction in anti-inflammation, antioxidation and regulation of lipid metabolism in rats with myocardial ischemia. Evid Based Complement Alternat Med 2011: 1-8.
19. Ming TJ, Qiu ZS, Fang GW, et al. (2004). Ginsenoside Rg2 protection against apoptosis in ischemia and reperfusion rat myocardium. Chin Pharmaco Bull 20: 480.
20. Mo X, Zhao N, Du X, et al. (2011). The protective effect of peony extract on acute myocardial infarction in rats. Phytomedicine 18: 451-7.
21. Vaturi M, Birnbaum Y. (2000). The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction. J Thromb Thrombolysis 10: 137-47.
22. Wang T, Yu X, Qu S, et al. (2010). Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats. Eur J Pharmacol 636: 121-5.
23. Wang WP, Chai CZ, Kou JP, Yu BY. (2011a). Comparison of clinical indications simulating deficiency of both qi and yin syndrome induced by two types of chronic intermittent hypoxia in mice. Chin J Exp Trad Med Formu 17: 171-6.
24. Wang YH, Qiu C, Wang DW, et al. (2011b). Identification of multiple constituents in the traditional Chinese medicine formula Sheng-Mai- San and rat plasma after oral administration by HPLC-DAD-MS/MS. J Pharm Biomed Anal 54: 1110-27.
25. Wu L, Ding XP, Zhu DN, et al. (2010). Study on the radical scavengers in the traditional Chinese medicine formula Sheng-Mai-San by HPLC-DAD coupled with chemiluminescence (CL) and ESI-MS/MS. J Pharm Biomed Anal 52: 438-45.
26. Wu W, Zhang XM, Liu PM, et al. (1995). Effects of panax notoginseng saponin Rg1 on cardiac electrophysiological properties and ventricular fibrillation threshold in dogs. Acta Pharmacol Sin 16: 459-63.
27. Xia R, Zhao B, Wu Y, et al. (2011). Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats. J Biomed Biotechnol 2011: 1-8.
28. Xie JT, Shao ZH, Vanden Hoek TL, et al. (2006). Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 532: 201-7.
29. Yang B, Li Y, Chen X. (1989). Correlation between protective effect of ginsenosides against myocardial ischemia and lipid peroxidation in rats. Asian Pacific J Pharmacol 4: 265-72.
30. Yang GD, Fang ZY, Liu Y, et al. (2011). Protective effects of Chinese traditional medicine buyang huanwu decoction on myocardial injury. Evid Based Complement Alternat Med 2011: 1-7.
31. Yang YL, Shi YR, Li JL, Chen YH. (2003). Advances in research of myocardial ischemia reperfusion injury. Adv Cardio Diseases 24: 116-21.
32. Yellon DM, Hausenloy DJ. (2007). Myocardial reperfusion injury. N Engl J Med 357: 1121-35.
33. Yim TK, Ko KM. (1999). Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Mol Cell Biochem 196: 151-6.
34. Zhan Y, Xu X, Jiang Y. (1994). Protective effects of ginsenoside on myocardiac ischemic and reperfusion injuries. Chin Med J (Engl) 74: 626-8.
35. Zhang S, Tan SY, Li SM, et al. (2010). The origin of Sheng-Mai-San. Liaoning J Tradi Chin Med 4: 1918-19.
36. Zhao BL, Li XJ, Liu GT, et al. (1990). Scavenging effect of schizandrins on active oxygen radicals. Cell Biol Int Rep 14: 99-109.
37. Zheng C, Hao H, Wang X, et al. (2009). Diagnostic fragment-ionbased extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI-ITTOF/MS: Shengmai injection as an example. J Mass Spectrom 44: 230-44.